title: SEDASYS(®), airway, oxygenation, and ventilation: anticipating and managing the challenges.
abstract: In May 2013, the FDA (Federal Drug Administration) approved SEDASYS(®), a device that enables non-anesthesia physicians to provide mild-to-moderate sedation to patients undergoing colonoscopy and esophagogastroduodenoscopy. SEDASYS(®) is the first among the devices being built to provide computer-assisted personalized sedation. Although the intention of this approval is to cut the anesthesia related expenses, it is likely to create new challenges to the users-both clinical and administrative-that might even increase the cost. Deep sedation is required frequently for a successful completion of the procedure, which poses unforeseen challenges. The present review aims to provide clear information to the users regarding pre-procedure assessment, possible sedation related complications and management options.
authors.affiliation: Department of Anesthesia and Intensive Care, Hospital of the University of Pennsylvania, Philadelphia, PA, USA, goudrab@uphs.upenn.edu.
authors.forename: Basavana Gouda
authors.initials: BG
authors.lastname: Goudra
authors.forename: Preet Mohinder
authors.initials: PM
authors.lastname: Singh
authors.forename: Vinay
authors.initials: V
authors.lastname: Chandrasekhara
mesh_terms: D016292:Procedural Sedation / Q000295:instrumentation* / Q000379:methods; D054810:Deep Sedation / Q000295:instrumentation* / Q000379:methods; D004360:Drug Therapy, Computer-Assisted / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000009:adverse effects; D008991:Monitoring, Physiologic / Q000295:instrumentation*
chemical_list: D006993:Hypnotics and Sedatives